BeiGene is a global biotechnology company that is rapidly transforming the landscape of cancer treatment. By focusing on high-quality, innovative medicine that is also affordable and accessible, they are tackling some of the most challenging medical issues of our time. With a workforce of over 10,000 colleagues spanning five continents, BeiGene fosters a uniquely collaborative culture that empowers scientists and professionals to push the boundaries of oncology research.
The company maintains a truly international presence with major administrative and research hubs in Basel, Beijing, and Cambridge. This distributed footprint allows them to tap into diverse talent pools and clinical ecosystems, ensuring that their breakthrough treatments reach the patients who need them most, regardless of their location.